Olema Pharmaceuticals, Inc.
OLMA
$4.42
$0.163.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -33.57M | -34.56M | -30.38M | -30.97M | -26.77M |
| Total Depreciation and Amortization | 116.00K | 95.00K | 94.00K | 88.00K | 88.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.99M | 3.91M | 3.82M | 2.84M | 2.40M |
| Change in Net Operating Assets | 2.18M | 3.53M | -1.09M | 4.54M | 5.80M |
| Cash from Operations | -26.28M | -27.02M | -27.56M | -23.50M | -18.48M |
| Capital Expenditure | 0.00 | 0.00 | -6.00K | -153.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.42M | 45.92M | -4.87M | -19.99M | -30.92M |
| Cash from Investing | -114.42M | 45.92M | -4.88M | -20.14M | -30.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 250.80M | 92.00K | 15.60M | 8.99M | 283.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.50M | 0.00 | 1.00K | -167.00K | 240.00K |
| Cash from Financing | 244.30M | 92.00K | 15.61M | 8.82M | 523.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.59M | 19.00M | -16.83M | -34.82M | -48.87M |